Maze Therapeutics, Inc. Common Stock MAZE Cash Flow Statement
| FY'25 | ||
|---|---|---|
| -$131.12M— | ||
| $2.4M-27.1% | ||
| $16.4M+70.0% | ||
| -$111.94M— | ||
| $794K-30.8% | ||
| -$170.96M-14,805% | ||
| —— | ||
| $275.34M+190% | ||
| -$7.57M— | ||
| -$112.73M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Maze Therapeutics, Inc. Common Stock generate?
- Maze Therapeutics, Inc. Common Stock (MAZE) generated -$121.5M in operating cash flow over the trailing twelve months.
- What is Maze Therapeutics, Inc. Common Stock's free cash flow?
- After $588.0K of capital expenditures, Maze Therapeutics, Inc. Common Stock's free cash flow was -$122.1M over the trailing twelve months.
- Where does Maze Therapeutics, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Maze Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
